Is Natraj Proteins overvalued or undervalued?

As of 17 September 2025, the valuation grade for Natraj Proteins has moved from very expensive to attractive, indicating a significant shift in its market perception. The company is currently considered undervalued, with a PE ratio of -15.06, an EV to EBITDA ratio of 25.18, and a Price to Book Value of 0.47. These figures suggest that the company is trading at a discount compared to its intrinsic value.
In comparison to its peers, Natraj Proteins shows a more favorable valuation profile than Gokul Agro, which has a PE ratio of 22.06 and is classified as very expensive, and Guj. Ambuja Exp, which is attractive with a PE of 21.29. Notably, Natraj's PEG ratio stands at 0.00, indicating potential for growth at a low price. While the stock has underperformed the Sensex over various periods, including a YTD decline of -9.91% compared to the Sensex's 5.83%, the recent grade change and attractive valuation suggest that it may present a buying opportunity for investors.